25 XP   0   0   10

Pharvaris BV
Buy, Hold or Sell?

Let's analyse Pharvaris together

PenkeI guess you are interested in Pharvaris BV. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Pharvaris BV. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Pharvaris BV

I send you an email if I find something interesting about Pharvaris BV.

Quick analysis of Pharvaris (30 sec.)










What can you expect buying and holding a share of Pharvaris? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.95
Expected worth in 1 year
$-1.45
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
$-4.41
Return On Investment
-21.9%

For what price can you sell your share?

Current Price per Share
$20.15
Expected price per share
$15.00 - $27.46
How sure are you?
50%

1. Valuation of Pharvaris (5 min.)




Live pricePrice per Share (EOD)

$20.15

Intrinsic Value Per Share

$-21.25 - $-25.43

Total Value Per Share

$-18.30 - $-22.48

2. Growth of Pharvaris (5 min.)




Is Pharvaris growing?

Current yearPrevious yearGrowGrow %
How rich?$158.8m$218.1m-$59.2m-37.3%

How much money is Pharvaris making?

Current yearPrevious yearGrowGrow %
Making money-$81.2m-$45.4m-$35.7m-44.0%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Pharvaris (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#294 / 1019

Most Revenue
#750 / 1019

Most Profit
#953 / 1019

Most Efficient
#185 / 1019

What can you expect buying and holding a share of Pharvaris? (5 min.)

Welcome investor! Pharvaris's management wants to use your money to grow the business. In return you get a share of Pharvaris.

What can you expect buying and holding a share of Pharvaris?

First you should know what it really means to hold a share of Pharvaris. And how you can make/lose money.

Speculation

The Price per Share of Pharvaris is $20.15. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pharvaris.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pharvaris, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.95. Based on the TTM, the Book Value Change Per Share is $-1.10 per quarter. Based on the YOY, the Book Value Change Per Share is $2.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pharvaris.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.51-7.5%-1.51-7.5%-0.85-4.2%-0.62-3.1%-0.62-3.1%
Usd Book Value Change Per Share-1.10-5.5%-1.10-5.5%2.1610.7%0.592.9%0.592.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.10-5.5%-1.10-5.5%2.1610.7%0.592.9%0.592.9%
Usd Price Per Share11.25-11.25-14.39-5.13-5.13-
Price to Earnings Ratio-7.45--7.45--17.02--4.89--4.89-
Price-to-Total Gains Ratio-10.21--10.21-6.66--1.77--1.77-
Price to Book Ratio3.81-3.81-3.55-1.47-1.47-
Price-to-Total Gains Ratio-10.21--10.21-6.66--1.77--1.77-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share20.15
Number of shares49
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-1.100.59
Usd Total Gains Per Share-1.100.59
Gains per Quarter (49 shares)-53.9928.94
Gains per Year (49 shares)-215.96115.76
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-216-2260116106
20-432-4420232222
30-648-6580347338
40-864-8740463454
50-1080-10900579570
60-1296-13060695686
70-1512-15220810802
80-1728-17380926918
90-1944-1954010421034
100-2160-2170011581150

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.05.00.00.0%0.05.00.00.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%4.01.00.080.0%4.01.00.080.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.05.00.0%0.00.05.00.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%4.01.00.080.0%4.01.00.080.0%

Fundamentals of Pharvaris

About Pharvaris BV

Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks which is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients which is under Phase 1 clinical trial. It operates in the Netherlands, Switzerland, and the United States. Pharvaris N.V. was incorporated in 2015 and is based in Leiden, the Netherlands.

Fundamental data was last updated by Penke on 2024-04-12 15:07:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Pharvaris BV.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pharvaris earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Pharvaris to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pharvaris BV:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--196.9%+196.9%
TTM--211.2%+211.2%
YOY--279.3%+279.3%
5Y--436.8%+436.8%
10Y--599.3%+599.3%
1.1.2. Return on Assets

Shows how efficient Pharvaris is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pharvaris to the Biotechnology industry mean.
  • -45.5% Return on Assets means that Pharvaris generated $-0.46 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pharvaris BV:

  • The MRQ is -45.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -45.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-45.5%TTM-45.5%0.0%
TTM-45.5%YOY-20.1%-25.4%
TTM-45.5%5Y-42.0%-3.5%
5Y-42.0%10Y-42.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-45.5%-13.6%-31.9%
TTM-45.5%-12.9%-32.6%
YOY-20.1%-11.9%-8.2%
5Y-42.0%-14.2%-27.8%
10Y-42.0%-16.2%-25.8%
1.1.3. Return on Equity

Shows how efficient Pharvaris is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pharvaris to the Biotechnology industry mean.
  • -51.1% Return on Equity means Pharvaris generated $-0.51 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pharvaris BV:

  • The MRQ is -51.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -51.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-51.1%TTM-51.1%0.0%
TTM-51.1%YOY-20.8%-30.3%
TTM-51.1%5Y-45.9%-5.3%
5Y-45.9%10Y-45.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-51.1%-17.0%-34.1%
TTM-51.1%-16.1%-35.0%
YOY-20.8%-15.4%-5.4%
5Y-45.9%-20.0%-25.9%
10Y-45.9%-21.1%-24.8%

1.2. Operating Efficiency of Pharvaris BV.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pharvaris is operating .

  • Measures how much profit Pharvaris makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pharvaris to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pharvaris BV:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--282.4%+282.4%
TTM--225.8%+225.8%
YOY--288.4%+288.4%
5Y--475.2%+475.2%
10Y--624.7%+624.7%
1.2.2. Operating Ratio

Measures how efficient Pharvaris is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Pharvaris BV:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.994-2.994
TTM-3.247-3.247
YOY-3.766-3.766
5Y-5.675-5.675
10Y-7.857-7.857

1.3. Liquidity of Pharvaris BV.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pharvaris is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 9.16 means the company has $9.16 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Pharvaris BV:

  • The MRQ is 9.155. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.155. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.155TTM9.1550.000
TTM9.155YOY30.283-21.128
TTM9.1555Y16.085-6.930
5Y16.08510Y16.0850.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.1553.930+5.225
TTM9.1554.251+4.904
YOY30.2835.436+24.847
5Y16.0856.045+10.040
10Y16.0856.383+9.702
1.3.2. Quick Ratio

Measures if Pharvaris is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pharvaris to the Biotechnology industry mean.
  • A Quick Ratio of 8.90 means the company can pay off $8.90 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pharvaris BV:

  • The MRQ is 8.901. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.901. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.901TTM8.9010.000
TTM8.901YOY30.067-21.166
TTM8.9015Y15.911-7.009
5Y15.91110Y15.9110.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.9013.629+5.272
TTM8.9014.065+4.836
YOY30.0675.390+24.677
5Y15.9115.993+9.918
10Y15.9116.277+9.634

1.4. Solvency of Pharvaris BV.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pharvaris assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pharvaris to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.11 means that Pharvaris assets are financed with 11.0% credit (debt) and the remaining percentage (100% - 11.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Pharvaris BV:

  • The MRQ is 0.110. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.110. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.110TTM0.1100.000
TTM0.110YOY0.034+0.076
TTM0.1105Y0.076+0.034
5Y0.07610Y0.0760.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1100.332-0.222
TTM0.1100.333-0.223
YOY0.0340.268-0.234
5Y0.0760.366-0.290
10Y0.0760.390-0.314
1.4.2. Debt to Equity Ratio

Measures if Pharvaris is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pharvaris to the Biotechnology industry mean.
  • A Debt to Equity ratio of 12.4% means that company has $0.12 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pharvaris BV:

  • The MRQ is 0.124. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.124. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.124TTM0.1240.000
TTM0.124YOY0.035+0.089
TTM0.1245Y0.083+0.041
5Y0.08310Y0.0830.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1240.380-0.256
TTM0.1240.389-0.265
YOY0.0350.334-0.299
5Y0.0830.432-0.349
10Y0.0830.465-0.382

2. Market Valuation of Pharvaris BV

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Pharvaris generates.

  • Above 15 is considered overpriced but always compare Pharvaris to the Biotechnology industry mean.
  • A PE ratio of -7.45 means the investor is paying $-7.45 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pharvaris BV:

  • The EOD is -13.343. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.449. Based on the earnings, the company is expensive. -2
  • The TTM is -7.449. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-13.343MRQ-7.449-5.893
MRQ-7.449TTM-7.4490.000
TTM-7.449YOY-17.022+9.572
TTM-7.4495Y-4.894-2.555
5Y-4.89410Y-4.8940.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-13.343-2.426-10.917
MRQ-7.449-2.552-4.897
TTM-7.449-2.656-4.793
YOY-17.022-4.143-12.879
5Y-4.894-6.252+1.358
10Y-4.894-6.108+1.214
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pharvaris BV:

  • The EOD is -15.137. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -8.451. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.451. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-15.137MRQ-8.451-6.686
MRQ-8.451TTM-8.4510.000
TTM-8.451YOY-16.261+7.810
TTM-8.4515Y-4.942-3.509
5Y-4.94210Y-4.9420.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-15.137-3.199-11.938
MRQ-8.451-3.259-5.192
TTM-8.451-3.552-4.899
YOY-16.261-5.617-10.644
5Y-4.942-8.326+3.384
10Y-4.942-8.689+3.747
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pharvaris is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.81 means the investor is paying $3.81 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Pharvaris BV:

  • The EOD is 6.824. Based on the equity, the company is overpriced. -1
  • The MRQ is 3.810. Based on the equity, the company is fair priced.
  • The TTM is 3.810. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD6.824MRQ3.810+3.014
MRQ3.810TTM3.8100.000
TTM3.810YOY3.549+0.261
TTM3.8105Y1.472+2.338
5Y1.47210Y1.4720.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD6.8241.947+4.877
MRQ3.8102.116+1.694
TTM3.8102.095+1.715
YOY3.5492.836+0.713
5Y1.4723.443-1.971
10Y1.4723.791-2.319
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Pharvaris BV.

3.1. Funds holding Pharvaris BV

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Fidelity Growth Compy Commingled Pl O1.86130.02931001200294003.0253
2024-02-29Fidelity Growth Company Fund1.41970.0294763668213002.8692
2024-01-31Fidelity Small Cap Growth1.3620.3821732607-884-0.1205
2024-02-29Fidelity Select Health Care1.32580.206771316729000.4083
2024-02-29Fidelity Advisor Health Care I0.85630.212346058918000.3923
2024-01-31Fidelity Small Cap Growth K60.4960.37342668148840.3324
2024-02-29Fidelity Growth Company K60.42520.028522871965002.925
2024-02-29Fidelity Series Growth Company0.39690.03121350056002.6936
2024-02-29Fidelity Blue Chip Growth0.33180.00717850000
2024-02-29APO Medical Opportunities R0.27540.415614816381538122.3835
2023-11-30MEDICAL BioHealth EUR Acc0.24490.357613173600
2024-02-29Fidelity Select Biotechnology0.2090.0525112407-66500-37.1701
2024-02-29Fidelity VIP Health Care Initial0.18890.19661016004000.3953
2024-02-29Fidelity Stock Selec All Cp0.14640.0294787668201.052
2024-02-29Fidelity VIP Stock Selector All Cap Init0.1190.03196400000
2024-02-29Candriam Eqs L Biotech C USD Cap0.0930.06985000000
2024-01-31Fidelity Asset Manager 50%0.08050.013643299-548-1.2498
2024-02-29Fidelity Blue Chip Growth K60.07580.00674076300
2024-01-31Fidelity Asset Manager 70%0.07180.017938648-1099-2.765
2024-02-29Fidelity Series Blue Chip Growth0.05930.00723190000
Total 10.0392.49855400046+82111+1.5%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Pharvaris BV compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.102-1.1020%2.160-151%0.591-287%0.591-287%
Book Value Per Share--2.9532.9530%4.055-27%1.874+58%1.874+58%
Current Ratio--9.1559.1550%30.283-70%16.085-43%16.085-43%
Debt To Asset Ratio--0.1100.1100%0.034+227%0.076+46%0.076+46%
Debt To Equity Ratio--0.1240.1240%0.035+255%0.083+49%0.083+49%
Dividend Per Share----0%-0%-0%-0%
Eps---1.510-1.5100%-0.845-44%-0.623-59%-0.623-59%
Free Cash Flow Per Share---1.331-1.3310%-0.885-34%-0.570-57%-0.570-57%
Free Cash Flow To Equity Per Share---1.160-1.1600%1.957-159%0.536-316%0.536-316%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---25.432--------
Intrinsic Value_10Y_min---21.253--------
Intrinsic Value_1Y_max---1.243--------
Intrinsic Value_1Y_min---1.208--------
Intrinsic Value_3Y_max---4.730--------
Intrinsic Value_3Y_min---4.449--------
Intrinsic Value_5Y_max---9.416--------
Intrinsic Value_5Y_min---8.564--------
Market Cap1083878575.000+44%605143125.000605143125.0000%774045295.000-22%275837684.000+119%275837684.000+119%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio6.824+44%3.8103.8100%3.549+7%1.472+159%1.472+159%
Pe Ratio-13.343-79%-7.449-7.4490%-17.022+128%-4.894-34%-4.894-34%
Price Per Share20.150+44%11.25011.2500%14.390-22%5.128+119%5.128+119%
Price To Free Cash Flow Ratio-15.137-79%-8.451-8.4510%-16.261+92%-4.942-42%-4.942-42%
Price To Total Gains Ratio-18.287-79%-10.210-10.2100%6.663-253%-1.774-83%-1.774-83%
Quick Ratio--8.9018.9010%30.067-70%15.911-44%15.911-44%
Return On Assets---0.455-0.4550%-0.201-56%-0.420-8%-0.420-8%
Return On Equity---0.511-0.5110%-0.208-59%-0.459-10%-0.459-10%
Total Gains Per Share---1.102-1.1020%2.160-151%0.591-287%0.591-287%
Usd Book Value--158841459.726158841459.7260%218111056.030-27%100806241.347+58%100806241.347+58%
Usd Book Value Change Per Share---1.102-1.1020%2.160-151%0.591-287%0.591-287%
Usd Book Value Per Share--2.9532.9530%4.055-27%1.874+58%1.874+58%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.510-1.5100%-0.845-44%-0.623-59%-0.623-59%
Usd Free Cash Flow---71606750.906-71606750.9060%-47601362.703-34%-30684792.678-57%-30684792.678-57%
Usd Free Cash Flow Per Share---1.331-1.3310%-0.885-34%-0.570-57%-0.570-57%
Usd Free Cash Flow To Equity Per Share---1.160-1.1600%1.957-159%0.536-316%0.536-316%
Usd Market Cap1083878575.000+44%605143125.000605143125.0000%774045295.000-22%275837684.000+119%275837684.000+119%
Usd Price Per Share20.150+44%11.25011.2500%14.390-22%5.128+119%5.128+119%
Usd Profit---81233107.159-81233107.1590%-45474095.012-44%-33502586.121-59%-33502586.121-59%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---1.102-1.1020%2.160-151%0.591-287%0.591-287%
 EOD+5 -3MRQTTM+0 -0YOY+1 -285Y+8 -2110Y+8 -21

4.2. Fundamental Score

Let's check the fundamental score of Pharvaris BV based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-13.343
Price to Book Ratio (EOD)Between0-16.824
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than18.901
Current Ratio (MRQ)Greater than19.155
Debt to Asset Ratio (MRQ)Less than10.110
Debt to Equity Ratio (MRQ)Less than10.124
Return on Equity (MRQ)Greater than0.15-0.511
Return on Assets (MRQ)Greater than0.05-0.455
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Pharvaris BV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.869
Ma 20Greater thanMa 5023.012
Ma 50Greater thanMa 10025.018
Ma 100Greater thanMa 20025.028
OpenGreater thanClose21.750
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets167,733
Total Liabilities18,474
Total Stockholder Equity149,259
 As reported
Total Liabilities 18,474
Total Stockholder Equity+ 149,259
Total Assets = 167,733

Assets

Total Assets167,733
Total Current Assets166,847
Long-term Assets886
Total Current Assets
Cash And Cash Equivalents 161,837
Net Receivables 382
Inventory 4,044
Other Current Assets 583
Total Current Assets  (as reported)166,847
Total Current Assets  (calculated)166,847
+/-0
Long-term Assets
Property Plant Equipment 626
Other Assets 260
Long-term Assets  (as reported)886
Long-term Assets  (calculated)886
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities18,225
Long-term Liabilities249
Total Stockholder Equity149,259
Total Current Liabilities
Short-term Debt 187
Accounts payable 5,979
Other Current Liabilities 12,058
Total Current Liabilities  (as reported)18,225
Total Current Liabilities  (calculated)18,225
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt249
Long-term Liabilities  (as reported)249
Long-term Liabilities  (calculated)249
+/-0
Total Stockholder Equity
Common Stock4,058
Retained Earnings -164,189
Accumulated Other Comprehensive Income 20,213
Other Stockholders Equity 289,177
Total Stockholder Equity (as reported)149,259
Total Stockholder Equity (calculated)149,259
+/-0
Other
Capital Stock4,058
Cash and Short Term Investments 161,837
Common Stock Shares Outstanding 33,586
Liabilities and Stockholders Equity 167,733
Net Debt -161,401
Net Invested Capital 149,259
Net Tangible Assets 149,259
Net Working Capital 148,622
Property Plant and Equipment Gross 692
Short Long Term Debt Total 437



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
> Total Assets 
4,796
5,434
20,598
101,100
212,090
167,733
167,733212,090101,10020,5985,4344,796
   > Total Current Assets 
4,796
5,434
20,585
100,952
211,567
166,847
166,847211,567100,95220,5855,4344,796
       Cash And Cash Equivalents 
4,795
5,385
20,326
98,629
209,353
161,837
161,837209,35398,62920,3265,3854,795
       Net Receivables 
1
26
211
570
700
382
382700570211261
       Other Current Assets 
0
23
48
1,213
6
583
58361,21348230
   > Long-term Assets 
0
0
13
148
523
886
8865231481300
       Property Plant Equipment 
0
0
13
49
351
626
626351491300
       Other Assets 
0
0
0
0
0
260
26000000
> Total Liabilities 
139
481
1,924
5,314
7,137
18,474
18,4747,1375,3141,924481139
   > Total Current Liabilities 
139
481
1,924
5,314
6,986
18,225
18,2256,9865,3141,924481139
       Short-term Debt 
0
0
0
0
99
187
187990000
       Accounts payable 
60
246
510
847
2,126
5,979
5,9792,12684751024660
       Other Current Liabilities 
78
235
1,414
4,467
4,761
12,058
12,0584,7614,4671,41423578
   > Long-term Liabilities 
60
246
510
847
151
249
24915184751024660
> Total Stockholder Equity
4,657
4,953
18,674
95,786
204,953
149,259
149,259204,95395,78618,6744,9534,657
   Common Stock
101
101
131
236
3,978
4,058
4,0583,978236131101101
   Retained Earnings -164,189-87,568-44,460-18,474-10,447-6,133
   Accumulated Other Comprehensive Income 
175
276
392
1,976
9,800
20,213
20,2139,8001,976392276175
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
10,514
15,023
36,542
138,034
278,743
289,177
289,177278,743138,03436,54215,02310,514



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-93,299
Operating Income-93,299-93,299
 
Operating Expense (+$)
Research Development63,013
Selling General Administrative30,287
Selling And Marketing Expenses-
Operating Expense93,29993,299
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-213
Net Interest Income213
 
Pretax Income (+$)
Operating Income-93,299
Net Interest Income213
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-106,720-79,666
EBIT - interestExpense = 0
-107,324
-107,324
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--106,720
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-106,720
Tax Provision-604
Net Income From Continuing Ops-107,324-107,324
Net Income-107,324
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-13,633-213
 

Technical Analysis of Pharvaris
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pharvaris. The general trend of Pharvaris is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pharvaris's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pharvaris BV.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 20.50 < 26.57 < 27.46.

The bearish price targets are: 20.98 > 19.38 > 15.00.

Tweet this
Pharvaris BV Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pharvaris BV. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pharvaris BV Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pharvaris BV. The current macd is -0.92065777.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pharvaris price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Pharvaris. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Pharvaris price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Pharvaris BV Daily Moving Average Convergence/Divergence (MACD) ChartPharvaris BV Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pharvaris BV. The current adx is 14.81.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Pharvaris shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Pharvaris BV Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pharvaris BV. The current sar is 24.27.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Pharvaris BV Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pharvaris BV. The current rsi is 33.87. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Pharvaris BV Daily Relative Strength Index (RSI) ChartPharvaris BV Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pharvaris BV. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pharvaris price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Pharvaris BV Daily Stochastic Oscillator ChartPharvaris BV Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pharvaris BV. The current cci is -160.37207014.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Pharvaris BV Daily Commodity Channel Index (CCI) ChartPharvaris BV Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pharvaris BV. The current cmo is -43.52502516.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Pharvaris BV Daily Chande Momentum Oscillator (CMO) ChartPharvaris BV Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pharvaris BV. The current willr is -94.55909944.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Pharvaris BV Daily Williams %R ChartPharvaris BV Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Pharvaris BV.

Pharvaris BV Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pharvaris BV. The current atr is 1.83972902.

Pharvaris BV Daily Average True Range (ATR) ChartPharvaris BV Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pharvaris BV. The current obv is 75,766,820.

Pharvaris BV Daily On-Balance Volume (OBV) ChartPharvaris BV Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pharvaris BV. The current mfi is 47.63.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Pharvaris BV Daily Money Flow Index (MFI) ChartPharvaris BV Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pharvaris BV.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-21MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-05BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-07MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.

6.3. Candlestick Patterns

Pharvaris BV Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pharvaris BV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.869
Ma 20Greater thanMa 5023.012
Ma 50Greater thanMa 10025.018
Ma 100Greater thanMa 20025.028
OpenGreater thanClose21.750
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Pharvaris with someone you think should read this too:
  • Are you bullish or bearish on Pharvaris? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pharvaris? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pharvaris BV

I send you an email if I find something interesting about Pharvaris BV.


Comments

How you think about this?

Leave a comment

Stay informed about Pharvaris BV.

Receive notifications about Pharvaris BV in your mailbox!